Moreover, targeted KRAS disruption mediated by HA-decorated CP/Ad−SS−GD/RNP nanocomplex was demonstrated to inhibit tumor growth and metastasis in colorectal cancer models. The gene discussed is KRAS; the disease is neoplasm.